Florian Huber

Ludwig Cancer Research — Switzerland

Immunology and Microbiology · Life Sciences

18h-index1.4kcitations44works9.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Immunotherapy and Immune Responses(16), Ferroptosis and cancer prognosis(14), vaccines and immunoinformatics approaches(10), Cancer Immunotherapy and Biomarkers(9), CAR-T cell therapy research(7)

Publications44 total

Tissue specificity and chromosomal alterations shape divergent immune programs in HRD tumors
2025Open Access
Defects in antigen processing and presentation: mechanisms, immune evasion and implications for cancer vaccine development
Nature reviews. Immunology·2025· 2 cited
Sensitive neoantigen discovery by real-time mutanome-guided immunopeptidomics
Nature Communications·2025· 5 citedOpen Access
Circulating tumor‐associated and neoantigen‐specific endogenous T cells in children treated for B‐acute lymphoblastic leukemia
HemaSphere·2025Open Access
A comprehensive proteogenomic pipeline for neoantigen discovery to advance personalized cancer immunotherapy
Nature Biotechnology·2024· 65 citedOpen Access
Predicting Antigen‐Specificities of Orphan T Cell Receptors from Cancer Patients with TCRpcDist
Advanced Science·2024· 6 citedOpen Access
Figure S4 from A Cluster of Evolutionarily Recent KRAB Zinc Finger Proteins Protects Cancer Cells from Replicative Stress–Induced Inflammation
2024Open Access
Figure S5 from A Cluster of Evolutionarily Recent KRAB Zinc Finger Proteins Protects Cancer Cells from Replicative Stress–Induced Inflammation
2024Open Access
Data from A Cluster of Evolutionarily Recent KRAB Zinc Finger Proteins Protects Cancer Cells from Replicative Stress–Induced Inflammation
2024Open Access
Data from A Cluster of Evolutionarily Recent KRAB Zinc Finger Proteins Protects Cancer Cells from Replicative Stress–Induced Inflammation
2024Open Access
Figure S1 from A Cluster of Evolutionarily Recent KRAB Zinc Finger Proteins Protects Cancer Cells from Replicative Stress–Induced Inflammation
2024Open Access
Figure S2 from A Cluster of Evolutionarily Recent KRAB Zinc Finger Proteins Protects Cancer Cells from Replicative Stress–Induced Inflammation
2024Open Access
Figure S2 from A Cluster of Evolutionarily Recent KRAB Zinc Finger Proteins Protects Cancer Cells from Replicative Stress–Induced Inflammation
2024Open Access
Figure S5 from A Cluster of Evolutionarily Recent KRAB Zinc Finger Proteins Protects Cancer Cells from Replicative Stress–Induced Inflammation
2024Open Access
Figure S3 from A Cluster of Evolutionarily Recent KRAB Zinc Finger Proteins Protects Cancer Cells from Replicative Stress–Induced Inflammation
2024Open Access
Immunopeptidomics-based identification of naturally presented non-canonical circRNA-derived peptides
Nature Communications·2024· 35 citedOpen Access
Figure S6 from A Cluster of Evolutionarily Recent KRAB Zinc Finger Proteins Protects Cancer Cells from Replicative Stress–Induced Inflammation
2024Open Access
Figure S6 from A Cluster of Evolutionarily Recent KRAB Zinc Finger Proteins Protects Cancer Cells from Replicative Stress–Induced Inflammation
2024Open Access
Figure S4 from A Cluster of Evolutionarily Recent KRAB Zinc Finger Proteins Protects Cancer Cells from Replicative Stress–Induced Inflammation
2024Open Access
Figure S1 from A Cluster of Evolutionarily Recent KRAB Zinc Finger Proteins Protects Cancer Cells from Replicative Stress–Induced Inflammation
2024Open Access
page 1 of 3Next →

Frequent Co-authors

Michal Bassani‐Sternberg(39), Justine Michaux(29), HuiSong Pak(24), Evarist Planet(19), Didier Trono(19), Olga Rosspopoff(16), Joana Carlevaro-Fita(16), Romain Forey(16), Sandra Offner(16), Cyril Pulver(16), George Coukos(15), Priscilla Turelli(15), Filipe Martins(15), Alexandre Harari(14), Brian J. Stevenson(13), Lana E. Kandalaft(10), Johanna Chiffelle(8), Markus Müller(7), Marion Arnaud(7), Sara Bobisse(6)